The effectiveness of a new surgical technique for the treatment of severe chronic pain stages was evaluated. For the last 140 years, the treatment of complex regional pain syndrome type II (CRPS II) has been an unsolved problem. Therapeutic approaches have included conventional pain medication, physical therapy, sympathetic blocks, transcutaneous or spinal cord stimulation, injections or infusion therapies, and sympathectomy. When used alone or in combination, these therapies often yield unfavorable results. The majority of physicians who treat patients with CRPS are convinced that a surgical treatment of the affected extremity only exacerbates the symptoms, especially its hallmark excruciating pain.
S
ince 1864, when Mitchell et al. 1, 2 first published the clinical observations made during the Civil War, several different names have been given to what they called ''causalgia, the most terrible of all the tortures which a nerve wound may inflict.'' Reflex sympathetic dystrophy, algodystrophy, Sudeck's atrophy, and sympathetic maintain pain syndrome are the most common synonyms for this chronic pain syndrome of unknown pathophysiology, which may arise spontaneously or after trauma, surgery, or visceral disease. 3, 4 The signs and symptoms are characterized by various combinations of pain, edema, autonomic vasomotor dysfunction, motor disorder, dystrophy, and atrophy. The severity of symptoms exceeds the expected amount of pain and the expected localization resulting from the tissue damage. It cannot be related to the autonomous zone of a single nerve. Over time, patients suffer from increasing pain, spreading edema, temperature disturbances, limitations in range of motion, dystrophy, and atrophy, 5, 6 often followed by depression and anxiety. 7, 8 To achieve a more uniform diagnosis, the umbrella terminology ''Complex Regional Pain Syndrome'' (CRPS type I/II), which contains no reference to the cause of its entity, was established in 1994 by the International Association for the Study of Pain. 9 In 1999, more stringent criteria were proposed by Bruehl et al. 10 Currently, there is no difference in frequency of any symptom or in treatment response between both subtypes. In type I, symptoms occur after a noxious event or a cause of immobilization. In contrast to type I, in type II, a definable nerve injury after trauma or surgery can be detected with electromyography or nerve conduction abnormalities.
10Y13
There are 1,500 to 2,000 new cases of CRPS diagnosed annually in Europe. The treatment period may last for several years, and because only one in five affected patients is able to resume employment, immense economic costs arise. 14 Today, it is widely accepted that disorders of the autonomic nervous system, as first described by Leriche 15 (vasomotor disequilibrium), and neurogenic inflammation, as first proposed by Sudeck, 16 are responsible for CRPS. Numerous studies have supported these pathomechanical theories. central control circuits. Therapeutic approaches include conventional pain medication, calcitonin, biphosphonates, limited courses of oral corticosteroids, physical therapy, sympathetic ganglion blocks, intravenous regional sympathetic blocks with guanethidine, transcutaneous electrical stimulation, spinal cord stimulation, intrathecal baclofen injections, continuous infusion of local anesthetics, epidural clonidine injection, and sympathectomy. 4,8,27Y32 Most treatments show acceptable results in the early stages of CRPS, whereas little or no positive effects are seen in progressive or chronic courses of the disease. The invasive methods are not only expensive and complex but also linked with a multitude of risks. 28, 33, 34 Alone or in combination, these therapies frequently show unfavorable results in chronic stages and do not aid the permanent resolution of symptoms. 27,28,34Y37 The majority of physicians treating patients with CRPS is convinced that surgical treatment of the affected extremity exacerbates the symptoms and should only be performed if a surgical problem (e.g., nerve compression) is the most likely underlying pathology that prolongs the syndromes.
38Y42 Otherwise, central sympathectomy seems to be the only acceptable surgical procedure. 8, 32, 33, 36, 43 Other surgical attempts, such as the periarterial sympathectomy, did not result in a favorable outcome. 8, 39, 40, 43, 44 The purpose of this study was to determine whether CRPS can be treated by resecting the regional subcutaneous veins that supply the affected regions of pain. This approach was developed on the basis of our experience with a single CRPS II patient. This patient reported a temporary disappearance of his symptoms during regional anesthesia administrated in conjunction with a ganglion operation. In CRPS type II animal models, a close anatomic interaction between sympathetic efferent and sensory afferent fibers can be detected after artificial nerve injury. Research indicates that sensory and sympathetic sprouting after a peripheral nerve injury is the cause of this novel connection, although the source of this sprouting (collateral and/or regenerative) remains unclear. 45 As the coupling between sympathetic and sensory fibers does not appear under physiologic conditions and is likely jointly responsible for CRPS, we attempted to dissect these sympathetic fibers.
The rationale behind our consideration for removing particular veins with their surrounding subcutaneous tissue is based on these animal models. In this prospective study, we surgically resected the subcutaneous tissue associated with the proximal portion of the CRPS II area in patients who had inadequate pain control for more than 6 months. We evaluated the outcomes of the surgical treatment on the basis of the intensity of postoperative pain, the patient's functional status, and the patient's quality of life.
METHODS

Patients
Since 1995, 160 patients were transferred from anesthesiology pain clinics to our department with a diagnosis of chronic neuroma or phantom pain and were henceforth treated with neuroma excision surgeries. As a result of these surgical procedures, 210 sensible nerves in the upper and lower limbs, the neck, the head, or in amputation stumps were dissected. According to Dellon et al., 46 the nervestumps were subsequently buried into a muscle, which lead to the prevention of axonal sprouting and recurrence of the neuroma.
Although allodynia and neuropathic pain could effectively be treated with a neuroma or phantom pain operation, in some patients a CRPS II occurred. Accordingly, the subsequent pain arose from areas that underwent complete resection of supplying peripheral sensory nerves due to the neuroma operation and were therefore fully denervated. Because of continuing burning pain, hyperalgesia, and varying degrees of edema or changes in skin blood flow, these patients were treated in cooperation with the anesthesiology pain clinic where the diagnosis of a CRPS II was made.
Sixteen of these patients met the inclusion criteria for our study as they had unsuccessful analgesic (combination of non-steroidal anti inflammatory drugs, tricyclic antidepressant, and anticonvulsant), physiotherapeutic (including transcutaneous electrical nerve stimulation), or invasive pain therapies (e.g., stellate ganglion block for the upper extremities or lumbar sympathic blocks for the lower extremities) for more than 6 months. None of our patients underwent sympathectomy.
Between May 2005 and October 2010, 16 CRPS type II patients (9 men and 7 women) with a mean age of 52 years (range: 34Y67 years) were treated with regional subcutaneous venous sympathectomy (RSVS). Most patients had long pain histories (mean of 9.1 years, range: 1.1Y26.5 years) and a mean of 5 (range: 0Y12) previous operations due to their primary pathology (Table 1 ). The mean duration of CRPS was 2.4 T 1.3 years. This duration corresponds with the atrophic Drucker stage III 47 (mean: 2.6, range: IYIII), which persists for more than 12 months after injury and is generally considered irreversible. On the basis of severe chronic pain (Mainz Pain Staging System EMPSS^: 2.59) and impaired use of the affected limb, all patients were considered handicapped in daily life, especially those having an affected hand (68%).
The mean pain intensity of the entire group was 8.8 on the visual analog scale (VAS; ranging from 0 to 10), and the mean overall health status was 41.4 measured with the Nottingham Health Profile (NHP) (range: 0 Eperfect health^to 100). The value of the MPSS was 2.6 (range: 1Y3; Table 1 ). One patient had two affected upper limbs that were treated consecutively.
The prospective study was approved by the Ethics Committee of the Medical University of Vienna, and all participants gave written informed consent.
Procedure
Localization of the CRPS Origin
In all patients, the CRPS occurred in a clearly defined region, which had previously been completely denervated. Regions included the forearm, wrist, hand, thenar eminence, thigh, knee, lower leg, ankle, or an amputation stump (Table 1 and Fig. 1 ).
The well-known symptoms of CRPS (especially the deep burning pain) could be provoked by palpitation of these surgically denervated areas. Finger tapping and the patient's response (no pain, beginning pain, and maximum pain) allowed us to localize the entire affected region and to identify the most proximal area from which pain could be triggered (Fig. 1) . This procedure could not be performed accurately in two patients who suffered from CRPS of the deep layers of their amputation stumps. In these two patients, the characteristic pain was sought with a peripheral nerve stimulator (Alphaplex Stimulation System, Hüttinger Elektronik GmbH, Umkirch, Germany). The cannula of this system allowed simultaneous nerve stimulation (imitating finger tapping) and injection (e.g., local anesthetic or methylene blue).
Test Infiltration
The detected proximal trigger area was subcutaneously infiltrated with 2 mL to 5 mL of 2% lidocaine (Xylanest purum 2%; Gebro Pharma GmbH, Fieberbrunn, Austria) to assure that the patient would benefit from an RSVS (Figs. 2 and 3) .
In certain cases when the peripheral nerve stimulator was used, the lidocaine injection was combined with methylene blue (Mayrhofer Pharmazeutika GmbH, Linz, Austria). This color served as a visible lead during the ensuing operation.
If the complete CRPS region could not be blocked with the first injection, a more extensive test infiltration was performed a few days later. There were no patients excluded from the study due to ineffective blockage.
Surgery
The previously determined and repeatedly (minimum 3 times) infiltrated proximal areas of the CRPS were operated on under local or general anesthesia. After incision of the skin, a subcutaneous area of È16 cm 2 (2.5 square inches) was removed en bloc between the dermis and muscle fascia. All prior detected and marked veins in the operating field were ligated or precisely coagulated (Figs. 4 and 5) . The tissue defect generated by this operation was closed using a full thickness or meshed skin graft. When the peripheral nerve stimulator and the methylene blue injection were used, all veins and fat located about 1 cm (0.4 inch) around the inked subcutaneous tissue were harvested.
Data Collection
Before the CRPS operation, all patients assessed their pain sensations on a VAS (0 = no pain and 10 = intolerable pain) and responded to an interview-administrated questionnaire known as the MPSS (ranging from stages I to III) to detect the severity of their chronic pain. The NHP was used to assess various areas of interest including energy, pain, emotional reaction, sleep, social isolation, mobility, and quality of life. The scores for each dimension range from 0 (normal health) to 100 (very poor health).
The first postoperative assessment was performed after 2 weeks to 6 weeks, and improvements had to be constant for at least 3 months to be considered a positive result of the operation. The median follow-up of our patients was 3.2 years. All patients were asked whether they would undergo the operation again. Finally, all complications of RSVS were documented.
Statistical Analysis
The paired Student's t test was used to determine the statistical significance of the differences before and after treatment. All p values were two tailed and differences were considered significant when the p value was G0.05.
RESULTS
Results of Test Infiltration
In all cases, the pain origin could be localized by finger tapping or stimulation with the peripheral nerve stimulator. During this procedure, we regularly observed excessive sweating, which could be explained by a disturbed autonomic nervous system.
Immediately after the injection of the local anesthetic, the disturbing pain vanished, and the patients' satisfaction was considered very high. However, it was only maintained for 1 hour to 2 hours. In addition, there was a notable decline of edema in five patients. These results were reproducible in a minimum of three sets of blocks.
Results of the Operation
In an effort to achieve a permanent analgesic result, a surgical RSVS was performed. Beneficial effects were noted immediately after the onset of the local anesthesia. When a general anesthesia was necessary, this effect was seen promptly after the operation.
The postoperative pain could easily be treated with nonsteroidal anti inflammatory drugs and lasted for a few days. No additional pain medication besides the established was administrated during the follow-up period. Twelve patients (75%) demonstrated a significant decrease in their pain scores after the surgery (Fig. 6) . The mean score on the VAS was 8.8 before the operation and 2.7 after the operation. These scores were significantly reduced by 6.1 points ( p G 0.001), but the individual values ranged from 0 to 10.
On the basis of the NHP, the most improvement was observed in the pain-related domain (64.5 preoperatively, 23.8 postoperatively, p G 0.001). Postoperative improvement of all spheres was statistically significant except for social isolation. The patients' energy improved from 38.1 to 14.5 ( p = 0.003), the emotional reactions from 24.9 to 15.7 ( p = 0.03), and the sleep from 71.3 to 44.1 ( p = 0.001). Social isolation, although In one patient, we did not achieve any positive change in pain sensation. The reasons why he responded to the infiltration but did not benefit from the operation are still unclear to us. Perhaps, there was a fixed central mechanism involved that could only slightly be influenced by peripheral blocking.
Overall, patient satisfaction was excellent, and all patients (even the one who did not benefit from the operation) stated that they would consider undergoing the RSVS procedure again in the future.
Complications
Three separate complications were noted postoperatively: residual pain in a smaller region that required a subsequent operation, disturbances in wound healing, and scar formation. In four cases (25%), smaller parts of the affected area remained painful. A second (in 3 of 4 patients, 18.7%) or third (in 1 of 4 patients, 6.3%) operation was performed on these patients. Disturbances of wound healing occurred in two cases (12.5%), generating an elongated wound closure and resulted in an unattractive scar.
DISCUSSION
Patients with chronic stages of CRPS type II are assumed to be resistant to the effects of analgesics or surgical intervention. The results of this study indicate that the relatively uncomplicated surgical procedure of regional subcutaneous resection may serve as an effective new treatment for CRPS type II. Of the 160 patients who underwent operations because of chronic neuroma or phantom pain in our department, 16 (10%) developed a CRPS II persisting longer than 6 months despite the use of standard medical therapy and suffered from severe pain although having a complete loss of epicritic sensibility. After nerve resection for posttraumatic neuralgia, the pain quality shifted from intolerable pricking and electrifying, caused by the disturbed epicritic sensibility, to burning. The patients indicated that an improvement in clinical signs was present; however, they still suffered from CRPS symptoms due to the disturbed protopathic sensibility. 4, 25 Therefore, a precise pain anamnesis (especially pain quality) is essential. 8 Subject classification was based on the International Association for the Study of Pain consensus standards. 9, 10 Despite the availability of these standards, making the correct diagnosis often causes problems. In a recent chart review from Dellon et al., 48 up to 80% of patients with a diagnosis of CRPS I had one or more injured nerves and should therefore have had a diagnosis of CRPS II. In this setting, they used diagnostic nerve blocks of joint and/or cutaneous afferents. When this blocking reduced the pain intensity on a VAS of more than five points, these patients were treated surgically (neurolysis, joint denervation, or neuroma resection) with exceptional good results. Similar results are reported by Birch after correcting the lesion of the nerve and of the adjacent axial artery in patients with CRPS. These results confirm that peripheral nerve surgery has its place in CRPS II treatment. 48, 49 In our prospective study, 16 patients (17 limbs) were treated with RSVS. Pain level, functional status, and healthrelated quality of life showed remarkable improvement. The NHP was used because the health-related quality of life is more severely affected in CRPS than in other chronic diseases, and the enhancement of its dimensions can verify the effectiveness of a treatment. 50 During the follow-up period (3.2 T 0.4 years), there were no serious complications noted. The wound healing disturbances were likely a result of the lack of blood supply after the removal of the subcutaneous tissue and were considered a minor complication. Subcutaneous veins of varying sizes could always be found in the operation field. In three patients, stripping of the macroscopically visible veins was implemented to avoid scarring. In these cases, the desired analgesic effect did not adequately encompass the entire painful region and required a second intervention. Additional interventions were mandatory in four patients who suffered from residual pain in a smaller region than previously treated. Presumably, this pain originated from collateral or divergent veins that were not detected during the examination and therefore not excised.
The results of this study indicate significant improvement on the affected limb after surgery. However, when compared with the healthy limb, many patients continued to express dissatisfaction relating to their original presenting complaint (primary diagnosis), functional deficits, transient hyperesthesia, and local anesthesia (Table 1) . Therefore, they were not completely satisfied and needed mental support and exact explanations of their ailment.
The current technique was based on studies indicating that a dysfunction of the sympathetic nervous system is accountable for the deep burning pain associated with this disorder. 17, 18, 20, 21, 23 It has been well established that existing or sprouting sympathetic nerve fibers are responsible for the pain associated with CRPS. 45 In skin samples of axotomized rats, sprouted sympathetic fibers were found to wind around sensory fibers, whereas no differences in the innervation patterns of sham-operated or healthy rats could be found. There is also evidence that after nerve injury, primary afferent neurons develop de novo >-adrenoceptors. 26, 51 It may be possible that these usually separated neurons interact at a very distal point, such as the skin, where noxious stimuli are detected and transmitted. The novel interaction between noradrenalin and sensory neurons can be demonstrated by injecting norepinephrine into the skin of patients with previously successfully sympathectomized or sympathetically blocked CRPS. 52, 53 This injection is markedly painful in the CRPS region but usually not in the contralateral extremity or in healthy individuals.
As our patients were completely denervated proximal to the CRPS pain area due to a neuroma operation, regeneration of these fibers alongside the peripheral cutaneous nerves was impossible and had to occur in an alternative manner. Removal of the sympathetic plexus, which courses with arterioles, does not aid pain reduction as shown by Leriche 39 , Livingston 40 , and Boome and Jha 44 and as we have experienced in the past. According to our results, we assume that the efferent sympathetic fibers divert far more proximally from the injured (or resected) peripheral nerve and then follow the subcutaneous veins into the periphery where they stimulate C-afferent nerve fibers. Thus, an RSVS would resect these regional sympathetic fibers coursing with the veins and in this way cause pain relief.
CRPS research has been conducted for 150 years. To date, veins are the only system that has not been addressed medically or surgically in previous studies. Birklein and Handwerker 17 and Arnold et al. 19 found that when compared with arteries, veins of patients with CRPS are hyperresponsive in the presence of catecholamines. Thus, there is evidence that veins play an important role in the pathogenesis and maintenance of the clinical signs associated with CRPS.
Nevertheless, we cannot safely say that the dramatic improvements did not arise by reason of an afferent denervation. The limitations of this study are the small sample size, which must be taken into consideration when interpreting the results, the highly restrictive selection of patients, the lack of a placebo-controlled control group, and the fact that the explanation for the effectiveness of RSVS stays a hypothesis. In this clinical study, only standard micropathology of the resected tissue was performed, which did not show any distinct pathologic changes. For the examination of specific sensory and sympathetic nerve fibers, the implementation of complex immunofluorescence would be necessary.
Our results support the hypothesis that CRPS is maintained by sympathetic fibers that diverge from major peripheral nerves and follow the vessels into the periphery. This divergence potentially proceeds proximal to the spot where we resected the peripheral nerve and thus proximal to the CRPS region. Our data could indicate that the sympathetic nerve fibers follow the distribution of veins. We think that by resecting these veins, we resected the efferent sympathetic nerve fibers and achieved a selective and complete sympathectomy of this region. Our research lends support to the theory that there is a circuit present between efferent sympathetic nerve fibers, regional veins, and C-afferent nerve fibers. This theory is supported by similar findings in rats where CRPS II arises from coupling between sympathetic postganglionic neurons and afferent sensory neurons at the site of injury to the nerve, which results in abnormal afferent impulses to the spinal cord. 45 Although further investigation in this area is warranted, we think that such a circuit is the anatomic justification for implementing RSVS.
